Literature DB >> 23041467

Effect of clustering of metabolic syndrome factors on capillary and cerebrovascular impairment.

Pietro Nazzaro1, Gabriella Schirosi, Domenico Mezzapesa, Marco Petruzzellis, Lucia Pascazio, Gabriella Serio, Lorenzo De Benedittis, Francesco Federico.   

Abstract

BACKGROUND: Hypertension and metabolic disorders, attended by impaired microcirculation, represent major risk factors for cerebrovascular impairment, as well as being individual components of the metabolic syndrome (MetS). Aim of the study was to establish whether mild hypertensives, aged ≤65years, may be affected by progressive microvascular damage impairing cerebrovascular perfusion, related to a progressive clustering of MetS components.
METHODS: Twenty-two normotensives with no MetS component (NTN-0), 29 hypertensives with no (HTN-0), 30 with one (HTN-1), 29 with two (HTN-2), 27 with three (HTN-3), 25 with all four (HTN-4) MetS components, were recruited. The study required office and twenty-four hour ambulatory blood pressure monitoring and video capillaroscopy. Functional (fCD), anatomical (aCD) and recruited (RECR) phalangeal skin capillarity were assessed. Cerebral vasodilatory reserve was measured by the breath-holding index (BHI), using transcranial Doppler, in HTN-1 and HTN-2 with MetS.
RESULTS: The fCD and aCD were reduced in hypertensives and progressively reduced in those with MetS, while RECR was also impaired. BHI was lower in HTN-2 than in HTN-1 (p<0.001). BHI was correlated with fCD in HTN-1 (.396, p: .046), HNT-2 (.497, p: .011), and with aCD in HTN-2 (.494, p: .012), by partial Pearson test. DISCUSSION: The findings show that hypertensives exhibit an increasing microvascular rarefaction with MetS progression and that an impaired cerebral perfusion occurs when the MetS is established. The data underline the importance of preventing MetS in mild hypertensives, as it causes microvascular damage and impairs cerebral arterial perfusion.
Copyright © 2012 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23041467     DOI: 10.1016/j.ejim.2012.08.017

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN: 0953-6205            Impact factor:   4.487


  8 in total

1.  Distinct temporal phases of microvascular rarefaction in skeletal muscle of obese Zucker rats.

Authors:  Jefferson C Frisbee; Adam G Goodwill; Stephanie J Frisbee; Joshua T Butcher; Robert W Brock; I Mark Olfert; Evan R DeVallance; Paul D Chantler
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-10-10       Impact factor: 4.733

2.  Sleep-disordered breathing and retinal microvascular diameter.

Authors:  Anoop Shankar; Paul E Peppard; Terry Young; Barbara E K Klein; Ronald Klein; F Javier Nieto
Journal:  Atherosclerosis       Date:  2012-10-24       Impact factor: 5.162

3.  Clustering of four major lifestyle risk factors among Korean adults with metabolic syndrome.

Authors:  Shin Ha; Hui Ran Choi; Yo Han Lee
Journal:  PLoS One       Date:  2017-03-28       Impact factor: 3.240

Review 4.  Characteristics and control of the 24-hour ambulatory blood pressure in patients with metabolic syndrome.

Authors:  Jian-Feng Huang; Yan Li; Jinho Shin; Yook-Chin Chia; Apichard Sukonthasarn; Yuda Turana; Chen-Huan Chen; Hao-Min Cheng; Arieska Ann Soenarta; Jam Chin Tay; Tzung-Dau Wang; Kazuomi Kario; Ji-Guang Wang
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-02-25       Impact factor: 3.738

Review 5.  Impact of Nutrition on Cerebral Circulation and Cognition in the Metabolic Syndrome.

Authors:  Laura Mellendijk; Maximilian Wiesmann; Amanda J Kiliaan
Journal:  Nutrients       Date:  2015-11-13       Impact factor: 5.717

6.  Impaired cognitive executive dysfunction in adult treated hypertensives with a confirmed diagnosis of poorly controlled blood pressure.

Authors:  Christian Spinelli; Maria Fara De Caro; Gabriella Schirosi; Domenico Mezzapesa; Lorenzo De Benedittis; Concetta Chiapparino; Gabriella Serio; Francesco Federico; Pietro Nazzaro
Journal:  Int J Med Sci       Date:  2014-05-29       Impact factor: 3.738

7.  Cerebral microvascular dysfunction in metabolic syndrome is exacerbated by ischemia-reperfusion injury.

Authors:  Nathalie Obadia; Marcos Adriano Lessa; Anissa Daliry; Raquel Rangel Silvares; Fabiana Gomes; Eduardo Tibiriçá; Vanessa Estato
Journal:  BMC Neurosci       Date:  2017-09-08       Impact factor: 3.288

Review 8.  Neuroprotection Targeting Protein Misfolding on Chronic Cerebral Hypoperfusion in the Context of Metabolic Syndrome.

Authors:  María I Herrera; Lucas D Udovin; Nicolás Toro-Urrego; Carlos F Kusnier; Juan P Luaces; Matilde Otero-Losada; Francisco Capani
Journal:  Front Neurosci       Date:  2018-05-31       Impact factor: 4.677

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.